Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Test characteristics of end-of-treatment PET scans in diffuse large b-cell lymphoma in a population-level cohort

Samantha Hershenfeld, Daniel McCormack, Ning Liu, Matthew Cheung

Blood (2025) 146 (Supplement 1): 8027.

https://doi.org/10.1182/blood-2025-8027

Published: 2025

Journal Articles

From fit to frail: Effectiveness and safety of fixed-dose carfilzomib in the treatment of multiple myeloma – a single-center, real world evidence in China

Menghao Wei, Xiaoman Sun, Min Song, Ning Liu, Wenyi Lu, Zunmin Zhu, Jie Shi

Blood (2025) 146 (Supplement 1): 7506.

https://doi.org/10.1182/blood-2025-7506

Published: 2025

Journal Articles

Integrating the cardiovascular-renal-metabolic syndrome（ckm）: Construction and validation of a comprehensive model for early identification of high-risk multiple myeloma

Xiaoman Sun, Menghao Wei, Min Song, Ning Liu, Zhenxing Gao, Wenyi Lu, Zunmin Zhu, Jie Shi

Blood (2025) 146 (Supplement 1): 2796.

https://doi.org/10.1182/blood-2025-2796

Published: 2025

Journal Articles

The association between neighbourhood walkability and diffuse large B-cell lymphoma: A population-based Study

Elliot Smith, Gillian Booth, Wing Chan, Ning Liu, Mithunan Ravindran, Matthew Cheung, Kelvin Chan, Abi Vijenthira, Peter Gozdyra, Ethan Lin, Lee Mozessohn

Blood (2025) 146 (Supplement 1): 8057.

https://doi.org/10.1182/blood-2025-8057

Published: 2025

Journal Articles

Symptom burden in patients with cancer and thromboembolism: A population-based matched cohort study

Deborah Siegal, Zoe O'Neill, Lena Nguyen, Ning Liu, Marc Carrier, Rinku Sutradhar

Blood (2025) 146 (Supplement 1): 704.

https://doi.org/10.1182/blood-2025-704

Published: 2025

Journal Articles

Optimizing ELN 2022: Developing and validating a dynamic prognostic model for AML using platelet change rates and MRD kinetics

Ning Liu, Menghao Wei, Xiaoman Sun, Min Song, Wenyi Lu, Wanjun Zhang, Jie Shi

Blood (2025) 146 (Supplement 1): 1612.

https://doi.org/10.1182/blood-2025-1612

Published: 2025

Journal Articles

Primary analysis of a multicenter, open-label, phase 2 study of sonrotoclax (BGB-11417) monotherapy in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL)

Blood (2025) 146 (Supplement 1): 5666.

https://doi.org/10.1182/blood-2025-5666

Published: 2025

Journal Articles

Outcomes and Predictors of Survival for Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Large Population-Based Analysis

Inna Gong, Michael Crump, Anca Prica, Andrew Calzavara, Ning Liu, Danielle Rodin, David Hodgson, Lee Mozessohn, Matthew C. Cheung, John Kuruvilla

Blood (2024) 144 (Supplement 1): 3092.

https://doi.org/10.1182/blood-2024-206056

Published: 2024

Journal Articles

Subsequent Primary Malignancies in Patients with Indolent B Cell Non-Hodgkin Lymphoma Receiving Frontline Bendamustine Rituximab Therapy

Gwynivere A Davies, Anca Prica, Zharmaine Ante, Ning Liu, Gregory R Pond, Amaris K Balitsky, Lee Mozessohn

Blood (2024) 144 (Supplement 1): 3749.

https://doi.org/10.1182/blood-2024-211926

Published: 2024

Journal Articles

Real-World Comparison of Healthcare Costs and Resource Utilization Among Patients with Relapsed-Refractory Large B-Cell Lymphoma Treated with CAR T-Cell Therapy Versus Historical Standard-of-Care: A Cost-Consequence Analysis in Ontario, Canada

Tiana Kordbacheh, Anca Prica, Kelvin KW Chan, Mahmood Aminilari, Zharmaine Ante, Ning Liu, Inna Y Gong, Sita D. Bhella, Michael Crump, Abi Vijenthira, John Kuruvilla, Robert Kridel, Christine I Chen, Vishal Kukreti, Chloe Yang, Nauman Malik, David Hodgson, Danielle Rodin

Blood (2024) 144 (Supplement 1): 2272.

https://doi.org/10.1182/blood-2024-201539

Published: 2024

Journal Articles

Anthracycline Exposure and Breast Cancer Risk in Female Hodgkin Lymphoma Survivors

Karla Machlab, Vivian Aghanya, Lee Mozessohn, Michael Crump, Danielle Rodin, Ning Liu, Anca Prica

Blood (2024) 144 (Supplement 1): 4432.

https://doi.org/10.1182/blood-2024-204618

Published: 2024

Journal Articles

FRAIL-HRU-AML: Impact of Frailty Assessment on Health Resource Utilization in Acute Myeloid Leukemia Patients: A Population-Based Study from Ontario, Canada

Gopila Gupta, Sho Podolsky, Ning Liu, Matthew C. Cheung, Aniket Bankar

Blood (2024) 144 (Supplement 1): 449.

https://doi.org/10.1182/blood-2024-209217

Published: 2024

Journal Articles

A Real-World Comparison of CAR T-Cell Therapy Versus a Historical Standard-of-Care Approach for Relapsed-Refractory Large B-Cell Lymphoma in Ontario, Canada

Tiana Kordbacheh, Anca Prica, Kelvin KW Chan, Mahmood Aminilari, Zharmaine Ante, Ning Liu, Inna Y Gong, Sita Bhella, Michael Crump, Abi Vijenthira, John Kuruvilla, Robert Kridel, Christine I Chen, Vishal Kukreti, Chloe Yang, Nauman Malik, David Hodgson, Danielle Rodin

Blood (2024) 144 (Supplement 1): 5134.

https://doi.org/10.1182/blood-2024-206375

Published: 2024

Journal Articles

Timing of End-of-Treatment PET Scans and Impact on Subsequent Testing in Diffuse Large B-Cell Lymphoma

Samantha A. Hershenfeld, Daniel McCormack, Ning Liu, Matthew C. Cheung

Blood (2024) 144 (Supplement 1): 5093.

https://doi.org/10.1182/blood-2024-202071

Published: 2024

Journal Articles

Assessing the Impact of Marginalization on Survival for Patients Undergoing Allogeneic Stem Cell Transplant in Ontario, Canada

Adam Suleman, Sho Podolsky, Ning Liu, Kelvin KW Chan, Sumedha Arya, Lisa Hicks, Matthew C. Cheung, Anca Prica

Blood (2023) 142 (Supplement 1): 5175.

https://doi.org/10.1182/blood-2023-185351

Published: 2023

Journal Articles

Assessing the Impact of Marginalization on Survival for Patients Undergoing Autologous Stem Cell Transplant in Ontario, Canada

Adam Suleman, Sho Podolsky, Ning Liu, Kelvin KW Chan, Sumedha Arya, Lisa Hicks, Matthew C. Cheung, Anca Prica

Blood (2023) 142 (Supplement 1): 2389.

https://doi.org/10.1182/blood-2023-173609

Published: 2023

Journal Articles

Outcomes of Transplant-Eligible and Transplant-Ineligible Patients with Mantle Cell Lymphoma in Ontario, Canada

Adam Suleman, Zharmaine Ante, Ning Liu, Michael Crump, Kelvin KW Chan, Matthew C. Cheung, Anca Prica

Blood (2023) 142 (Supplement 1): 1665.

https://doi.org/10.1182/blood-2023-177788

Published: 2023

Journal Articles

The Impact of Drug Interactions on Outcomes in Ibrutinib-Treated Patients with Chronic Lymphocytic Leukemia in Routine Clinical Care: A Population-Based Cohort Study

Tuan Hoang, Matthew C. Cheung, Kelvin KW Chan, Cindy Lau, Ning Liu, Husam Abdel-Qadir, David Juurlink, Anca Prica, Alia Thawer, Abi Vijenthira, Lee Mozessohn

Blood (2022) 140 (Supplement 1): 2159–2160.

https://doi.org/10.1182/blood-2022-158768

Published: 2022

Journal Articles

The Impact of Marginalization on Diffuse Large B-Cell Lymphoma Overall Survival: A Retrospective Cohort Study

Sumedha Arya, Lee Mozessohn, Inna Gong, Neil Faught, Ning Liu, Simron Singh, Kelvin Chan, Matthew Cheung

Blood (2021) 138 (Supplement 1): 341.

https://doi.org/10.1182/blood-2021-146642

Published: 2021

Journal Articles

The Impact of Oral Hypoglycemics and Statins on Outcomes in Myelodysplastic Syndromes

Eugene Brailovski, Qing Li, Ning Liu, Brian Leber, Dina Khalaf, Mitchell Sabloff, Grace Christou, Karen Yee, Lisa Chodirker, Anne Parmentier, Mohammed Siddiqui, Alexandre Mamedov, Liying Zhang, Ying Liu, Craig C. Earle, Matthew Cheung, Nicole Mittman, Rena J. Buckstein, Lee Mozessohn

Blood (2021) 138 (Supplement 1): 3064.

https://doi.org/10.1182/blood-2021-149855

Published: 2021

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Test characteristics of end-of-treatment PET scans in diffuse large b-cell lymphoma in a population-level cohort

From fit to frail: Effectiveness and safety of fixed-dose carfilzomib in the treatment of multiple myeloma – a single-center, real world evidence in China

Integrating the cardiovascular-renal-metabolic syndrome（ckm）: Construction and validation of a comprehensive model for early identification of high-risk multiple myeloma

The association between neighbourhood walkability and diffuse large B-cell lymphoma: A population-based Study

Symptom burden in patients with cancer and thromboembolism: A population-based matched cohort study

Optimizing ELN 2022: Developing and validating a dynamic prognostic model for AML using platelet change rates and MRD kinetics

Primary analysis of a multicenter, open-label, phase 2 study of sonrotoclax (BGB-11417) monotherapy in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL)

Outcomes and Predictors of Survival for Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Large Population-Based Analysis

Subsequent Primary Malignancies in Patients with Indolent B Cell Non-Hodgkin Lymphoma Receiving Frontline Bendamustine Rituximab Therapy

Real-World Comparison of Healthcare Costs and Resource Utilization Among Patients with Relapsed-Refractory Large B-Cell Lymphoma Treated with CAR T-Cell Therapy Versus Historical Standard-of-Care: A Cost-Consequence Analysis in Ontario, Canada

Anthracycline Exposure and Breast Cancer Risk in Female Hodgkin Lymphoma Survivors

FRAIL-HRU-AML: Impact of Frailty Assessment on Health Resource Utilization in Acute Myeloid Leukemia Patients: A Population-Based Study from Ontario, Canada

A Real-World Comparison of CAR T-Cell Therapy Versus a Historical Standard-of-Care Approach for Relapsed-Refractory Large B-Cell Lymphoma in Ontario, Canada

Timing of End-of-Treatment PET Scans and Impact on Subsequent Testing in Diffuse Large B-Cell Lymphoma

Assessing the Impact of Marginalization on Survival for Patients Undergoing Allogeneic Stem Cell Transplant in Ontario, Canada

Assessing the Impact of Marginalization on Survival for Patients Undergoing Autologous Stem Cell Transplant in Ontario, Canada

Outcomes of Transplant-Eligible and Transplant-Ineligible Patients with Mantle Cell Lymphoma in Ontario, Canada

The Impact of Drug Interactions on Outcomes in Ibrutinib-Treated Patients with Chronic Lymphocytic Leukemia in Routine Clinical Care: A Population-Based Cohort Study

The Impact of Marginalization on Diffuse Large B-Cell Lymphoma Overall Survival: A Retrospective Cohort Study

The Impact of Oral Hypoglycemics and Statins on Outcomes in Myelodysplastic Syndromes

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only